Feature Channels:

Vaccines

Add to Favorites Subscribe Share
fbshare-Vaccines

Showing results

110 of 1091
UM_School_Medicine.png

Article ID: 719390

UM School of Medicine’s Center for Vaccine Development and Global Health Receives NIH Contract for Influenza Research

University of Maryland School of Medicine

The National Institute of Allergy and Infectious Diseases research contract is one of the largest ever awarded to UMSOM and includes an initial award of approximately $2.5 million to conduct clinical testing of influenza vaccines. Total funding over seven years could be as much as $201 million if all options are exercised in the NIAID contract.

Released:
20-Sep-2019 2:05 PM EDT
PennMed_logo.png
  • Embargo expired:
    20-Sep-2019 2:00 PM EDT

Article ID: 719374

New Penn-Developed Vaccine Prevents Herpes in Mice, Guinea Pigs

Perelman School of Medicine at the University of Pennsylvania

A novel vaccine at Penn Medicine protected almost all animal subjects exposed to the herpes virus

Released:
20-Sep-2019 1:00 PM EDT
idsanoclipspelledout2.png

Article ID: 719341

Senate Domestic, Foreign Funding Bills Recognize, but Fall Short of Needs for Critical Infectious Disease Responses

Infectious Diseases Society of America (IDSA)

Spending bills released by Senate Appropriations Committee Wednesday demonstrate encouraging recognition of some of the most urgent health challenges threatening individual and public health at home and abroad. At the same time, the bills fall short of the comprehensive commitments necessary to fully effective responses.

Released:
20-Sep-2019 9:00 AM EDT

Law and Public Policy

Newswise: 211171_web.jpg

Article ID: 719109

'Death Star' bacterial structures that inject proteins can be tapped to deliver drugs

San Diego State University

By scraping tubeworms off the bottom of boats in the San Diego harbor to study them, San Diego State University

Released:
17-Sep-2019 1:05 PM EDT

Research Results

Channels:

All Journal News, Biotech, Cancer, Cell Biology, Vaccines,

Languages:

English

New Logo.png

Article ID: 719086

UChicago-led effort receives Grand Challenges Grant for research developing universal influenza vaccine

University of Chicago Medical Center

Patrick Wilson, PhD, professor of medicine and rheumatology at the University of Chicago, and a group of researchers from three other institutions have received aGrand Challenge for Universal Influenza Vaccine Development grant – a $12 million initiative funded by the Bill & Melinda Gates Foundation and Flu Lab.

Released:
17-Sep-2019 11:05 AM EDT
Newswise: Can scientists predict which cancer markers are likely to trigger an immune response?

Article ID: 718890

Can scientists predict which cancer markers are likely to trigger an immune response?

University of North Carolina Health Care System

In a study published in the journal Cancer Immunology Research, University of North Carolina Lineberger Comprehensive Cancer Center researchers reported on the discovery of a method for predicting whether abnormal proteins produced by cancer cells could trigger an immune response.

Released:
12-Sep-2019 11:05 AM EDT

Article ID: 718761

Broad-spectrum antivirals could tip the balance against virus threats

Morgridge Institute for Research

In the game against an essentially unlimited pool of virus threats, humanity is seriously outmatched. In order to shift the balance, scientists need to change the game.

Released:
11-Sep-2019 1:05 AM EDT
BU_SUNY_logo.png

Article ID: 718562

Paid Family Leave Improves Vaccination Rates in Infants

Binghamton University, State University of New York

Parents who take paid family leave after the birth of a newborn are more likely to have their child vaccinated on time compared to those who do not, according to new research from Binghamton University, State University of New York.

Released:
9-Sep-2019 9:00 AM EDT
Newswise: Multimillion-Dollar Grant Funds New Vaccine Effort to Prevent Strep Throat Infections

Article ID: 718355

Multimillion-Dollar Grant Funds New Vaccine Effort to Prevent Strep Throat Infections

University of California San Diego Health

CARB-X, an international funder of efforts to fight antimicrobial resistance, is awarding up to $15 million to develop a strep throat vaccine based on original research at UC San Diego.

Released:
3-Sep-2019 11:05 AM EDT

Showing results

110 of 1091

Chat now!